Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Optoceutics ApS
APS
Active
Advertising protection
CVR 39769689
Nørrebrogade 45C, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 7 years old
6 employees
www.optoceutics.com
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Optoceutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
NM
Ngoc Mai Thi Nguyen
Chief Executive Officer
Chief Executive Officer
2018
MS
Marcus Schultz Carstensen
Management
Management
2019
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
KA
Kaare Agerholm Danielsen
Board of Directors
Board of Directors
2020
VL
Vivienne L'Ecuyer Ming
Board of Directors
Board of Directors
2019
JB
Jes Broeng
Chairman
Chairman
2025
Former (2)
DL
David Lee Hardwick
Chairman
Chairman
2023 – 2025
RJ
Rasmus Just
Chairman
Chairman
2019 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Danielsen 2 ApS
Company
25–33.32%
25–33.32%
2022
Ngoc Mai Thi Nguyen
Individual
15–19.99%
15–19.99%
2022
M. S. C. HOLDING ApS
Company
10–14.99%
10–14.99%
2024
Vjack Holding ApS
Company
5–9.99%
5–9.99%
2020
Sebastian Scripps
Individual
5–9.99%
5–9.99%
2023
BROENG CONSULT ApS
Company
5–9.99%
5–9.99%
2018
CHRISTIAN NIELSENS FOND
Company
5–9.99%
5–9.99%
2019
Lunox ApS
Company
5–9.99%
5–9.99%
2018
LUCAS INNOVATION ApS
Company
5–9.99%
5–9.99%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Optoceutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network